The ingredient-level mechanisms and studies covered above don't establish a measurable GLP-1 effect from the finished product at its labeled serving sizes, which sit well below the doses used in that research
Conventional endocrinologists often focus on TSH levels (from your pituitary gland) and perhaps free T4 levels, but thats not close to enough to get the full picture of your diagnosis
Hypertension Canadas 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
We will have a study on this soon, but current data show tirzepatide, the strongest of these medicines, has a low 20% lean mass loss (which isnt all muscle btw)
In particular, improving first-submission approval by even 10 percentage points (say, via better PA documentation) can have large downstream impact on prescription volume
NovoCare cut Wegovy cash price to $349 per month (or $199 for first-time low-dose patients)